Inactivation of mitochondrial succinate dehydrogenase by adriamycin activated by horseradish peroxidase and hydrogen peroxide

Chemico-Biological Interactions

Volumn 145, Issue 1, 2003, Pages 67-75

  Muraoka, Sanae ^a   Miura, Toshiaki ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Adriamycin; Anthracycline; Creatine kinase; Horseradish peroxidase; Succinate dehydrogenase

Indexed keywords

ACLARUBICIN; ANTHRACYCLINE ANTIBIOTIC AGENT; CRESOL; CYTOCHROME C OXIDASE; DAUNORUBICIN; DIMETHYL SULFOXIDE; DOXORUBICIN; ENZYME INHIBITOR; EPIRUBICIN; GLUTATHIONE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IDARUBICIN; IRON; IRON CHELATE; LIPID; MANNITOL; MITOCHONDRIAL ENZYME; OXYGEN; PIRARUBICIN; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HEART MITOCHONDRION; NONHUMAN; SWINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; ELECTRON TRANSPORT; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; MITOCHONDRIA, HEART; REACTIVE OXYGEN SPECIES; SUCCINATE DEHYDROGENASE; SWINE;

ARMORACIA RUSTICANA; SUS SCROFA;

EID: 0037422412     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(02)00239-9     Document Type: Article

References (42)

1. Carter S.K. The clinical evaluation of analogs - III. Anthracyclines. Cancer Chemother. Pharmacol. 4:1980;5-10.
2. Young R.C., Ozols R.F., Myers C.E. The anthracycline antineoplastic drugs. N. Engl. J. Med. 305:1981;139-153.
3. Lenaz L., Page J. Cardiotoxicity of adriamycin related anthracyclines. Cancer Treat. Rev. 3:1976;111-120.
4. Singal P.K., Iliskovic N., Li T., Kumar D. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 11:1997;931-936.
5. Doroshow J.H., Davies K.J. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261:1986;3068-3074.
6. Davies K.J., Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261:1986;3060-3067.
7. Mimnaugh E.G., Trush M.A., Bhatnagar M., Gram T.E. Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin. Biochem. Pharmacol. 34:1985;847-856.
8. Kolodziejczyk P., Reszka K., Lown W. Enzymatic oxidative activation of 5-iminodaunorubicin. Biochem. Pharmacol. 38:1989;803-809.
9. Miura T., Muraoka S., Fujimoto Y. Inactivation of creatine kinase by adriamycin during interaction with horseradish peroxidase. Biochem. Pharmacol. 60:2000;95-99.
10. Watts D.C. Creatine kinase. Boyer P.D. The Enzymes VII. 1973;383-455 Academic Press, New York and London.
11. Marcillat O., Zhang Y., Davies K.J. Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. Biochem. J. 259:1989;181-189.
12. Platel D., Pouna P., Bonoron-Adele S., Robert J. Comparative cardiotoxicity of idarubicin and doxorubicin using the isolated perfused rat heart model. Anticancer Drugs. 10:1999;671-676.
13. Hirano S., Wakazono K., Agata N., Iguchi H. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat. Drugs Exp. Clin. Res. 20:1994;153-160.
14. Temma K., Akera T., Chugun A., Kondo H., Hagane K., Hirano S. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart. Eur. J. Pharmacol. 234:1993;173-181.
15. Crane F.L., Glenn J.L., Green D.E. Studies on the electron transfer system. IV. The electron transfer particle. Biochim. Biophys. Acta. 22:1956;475-487.
16. Redinbaugh M.G., Turley R.B. Adaptation of the bicinchoninic acid protein assay for use with micrometer plates and sucrose gradient fraction. Anal. Biochem. 153:1986;267-271.
17. Ackrell B.A., Kearney E.B., Singer T.P. Mammalian succinate dehydrogenase. Methods Enzymol. 53:1978;466-483.
18. Hatefi Y. Preparation and properties of NADH: ubiquinone oxidoreductase (complex I), EC 1.6.5.3. Methods Enzymol. 53:1987;11-14.
19. Appelmans F., Wittiaux R., de Duve C. The association of acid phosphate with a special class of cytoplasmic granules in rat liver. Biochem. J. 59:1955;438-445.
20. Das D., Banerjee R.K. Effect of stress on the antioxidant enzymes and gastric ulceration. Mol. Cell Biochem. 125:1993;115-125.
21. Mimnaugh E.G., Kennedy K.A., Trush M.A., Sinha B.K. Adriamycin-enhanced membrane lipid peroxidation in isolated rat nuclei. Cancer Res. 45:1985;3296-3304.
22. Minotti G. NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidation. Arch. Biochem. Biophys. 277:1990;268-276.
23. 3+-induced inactivation of rat heart mitochondrial creatine kinase: sensitivity to lipid peroxidation. Biol. Pharm. Bull. 17:1994;1220-1223.
24. Demant E.J., Jensen P.K. Destruction of phospholipids and respiratory-chain activity in pig-heart submitochondrial particles induced by an adriamycin-iron complex. Eur. J. Biochem. 132:1983;551-556.
25. Beckman, Siedow J.N. Bactericidal agents generated by the peroxidase-catalyzed oxidation of para-hydroquinones. J. Biol. Chem. 260:1985;14604-14609.
26. Scholte H.R. The separation and enzymatic characterization of inner and outer membranes of rat-heart mitochondria. Biochim. Biophys. Acta. 330:1973;283-293.
27. Handa K., Sato S. Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation. Gann. 66:1975;43-47.
28. Bachur N.R., Gordon S.L., Gee V., Kon H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA. 76:1979;954-957.
29. Miura T., Muraoka S., Ogiso T. Adriamycin-induced lipid peroxidation of erythrocyte membranes in the presence of ferritin and the inhibitory effect of ceruloplasmin. Biol. Pharm. Bull. 16:1993;664-667.
30. 3+. Pharmacol. Toxicol. 69:1991;296-300.
31. Minotti G., Aust S.D. The role of iron in oxygen radical mediated lipid peroxidation. Chem. -Biol. Interact. 71:1989;1-19.
32. +) complex: a possible mechanism of nigrostriatal cell damage. Arch. Biochem. Biophys. 283:1990;334-341.
33. Rice-Evans C., Burdon R. Free radical-lipid interactions and their pathological consequences. Prog. Lipid Res. 32:1993;71-110.
34. 3+-ADP-EDTA systems. Less involvement of hydroxyl radical and a great importance of proposed perferryl ion complexes in lipid peroxidation. Biochim. Biophys. Acta. 753:1983;411-421.
35. Decorti G., Bartoli Klugmann F., Mallardi F., Klugmann S., Benussi B., Grill V., Baldini L. Effects of ICRF 159 on adriamycin-induced cardiomyopathy in rats. Cancer Lett. 19:1983;77-83.
36. Goormaghtigh E., Chatelain P., Caspers J., Ruysschaert J.M. Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity. Biochem. Pharmacol. 29:1980;3003-3010.
37. Goormaghtigh E., Chatelain P., Caspers J., Ruysschaert J.M. Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochim. Biophys. Acta. 597:1980;1-14.
38. Brenner D.E., Galloway S., Cooper J., Noone R., Hande K.R. Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography. Cancer Chemother. Pharmacol. 14:1985;139-145.
39. Greene R.F., Collins J.M., Jenkins J.F., Speyer J.L., Myers C.E. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res. 43:1983;3417-3421.
40. Reszka K.J., McCormick M.L., Britigan B.E. Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubicin and doxorubicin. Biochemistry. 40:2001;15349-15361.
41. Keilin D., Hartee E.F. Catalase, peroxidase and metmyoglobin as catalysts of coupled peroxidatic reactions. Biochem. J. 60:1955;310-325.
42. Whitburn K.D. The interaction of oxymyoglobin with hydrogen peroxide: the formation of ferrylmyoglobin at moderate excesses of hydrogen peroxide. Arch. Biochem. Biophys. 253:1987;419-430.